Morgan Stanley’s CEL-SCI Corp CVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43 Buy
41
+2
+5% +$4 ﹤0.01% 8135
2026
Q1
$125 Sell
39
-20
-34% -$93 ﹤0.01% 7761
2025
Q4
$310 Sell
59
-414
-88% -$3.04K ﹤0.01% 7583
2025
Q3
$4.35K Sell
473
-14
-3% -$110 ﹤0.01% 7127
2025
Q2
$1.11K Buy
487
+9
+2% +$47 ﹤0.01% 7324
2025
Q1
$3.3K Sell
478
-210
-31% -$2.27K ﹤0.01% 7083
2024
Q4
$8.26K Buy
688
+210
+44% +$4.84K ﹤0.01% 6869
2024
Q3
$15.2K Sell
478
-309
-39% -$10.9K ﹤0.01% 6591
2024
Q2
$27.4K Buy
787
+183
+30% +$7.8K ﹤0.01% 6360
2024
Q1
$34.6K Sell
604
-843
-58% -$59.6K ﹤0.01% 6343
2023
Q4
$118K Buy
1,447
+804
+125% +$50.1K ﹤0.01% 5881
2023
Q3
$24.1K Sell
643
-84
-12% -$4.02K ﹤0.01% 6428
2023
Q2
$52.6K Sell
727
-117
-14% -$8.51K ﹤0.01% 6191
2023
Q1
$58.8K Sell
844
-223
-21% -$17.5K ﹤0.01% 6220
2022
Q4
$75.2K Sell
1,067
-252
-19% -$22.2K ﹤0.01% 6105
2022
Q3
$122K Sell
1,319
-3,660
-74% -$441K ﹤0.01% 5978
2022
Q2
$671K Buy
4,979
+1,697
+52% +$177K ﹤0.01% 5266
2022
Q1
$386K Buy
3,282
+558
+20% +$90.8K ﹤0.01% 5560
2021
Q4
$581K Buy
2,724
+306
+13% +$93.7K ﹤0.01% 5455
2021
Q3
$797K Sell
2,418
-118
-5% -$34.4K ﹤0.01% 5199
2021
Q2
$659K Buy
2,536
+921
+57% +$570K ﹤0.01% 5349
2021
Q1
$737K Sell
1,615
-772
-32% -$422K ﹤0.01% 4923
2020
Q4
$835K Buy
2,387
+434
+22% +$171K ﹤0.01% 4765
2020
Q3
$747K Sell
1,953
-46
-2% -$18.1K ﹤0.01% 4413
2020
Q2
$895K Buy
1,999
+567
+40% +$233K ﹤0.01% 4257
2020
Q1
$495K Sell
1,432
-1,570
-52% -$574K ﹤0.01% 4372
2019
Q4
$824K Sell
3,002
-5,451
-64% -$1.29M ﹤0.01% 4645
2019
Q3
$2.27M Buy
8,453
+7,544
+830% +$1.77M ﹤0.01% 3655
2019
Q2
$228K Buy
909
+98
+12% +$17.7K ﹤0.01% 4965
2019
Q1
$86K Sell
811
-230
-22% -$19.7K ﹤0.01% 5459
2018
Q4
$90K Buy
1,041
+541
+108% +$52.1K ﹤0.01% 5588
2018
Q3
$60K Buy
500
+163
+48% +$9.37K ﹤0.01% 5827
2018
Q2
$9K Buy
337
+333
+8,325% +$24.6K ﹤0.01% 6324
2018
Q1
$0 Sell
4
-1
-20% -$56 ﹤0.01% 6627
2017
Q4
$0 Buy
5
+1
+25% +$54 ﹤0.01% 6579
2017
Q3
$0 Buy
4
+1
+33% +$63 ﹤0.01% 6543
2017
Q2
$0 Hold
3
﹤0.01% 6596
2017
Q1
$0 Hold
3
﹤0.01% 6579
2016
Q4
$0 Buy
3
+1
+50% +$154 ﹤0.01% 6528
2016
Q3
$0 Sell
2
-1
-33% -$339 ﹤0.01% 6513
2016
Q2
$1K Hold
3
﹤0.01% 6416
2016
Q1
$1K Hold
3
﹤0.01% 6461
2015
Q4
$0 Sell
3
-8
-73% -$3.12K ﹤0.01% 6687
2015
Q3
$4K Buy
11
+3
+38% +$1.37K ﹤0.01% 6413
2015
Q2
$4K Buy
8
+1
+14% +$634 ﹤0.01% 6443
2015
Q1
$6K Sell
7
-1
-13% -$655 ﹤0.01% 6307
2014
Q4
$3K Hold
8
﹤0.01% 6392
2014
Q3
$6K Sell
8
-3
-27% -$2.41K ﹤0.01% 6296
2014
Q2
$10K Hold
11
﹤0.01% 6185
2014
Q1
$12K Buy
11
+8
+267% +$6.92K ﹤0.01% 6083
2013
Q4
$1K Buy
+3
New +$1.84K ﹤0.01% 6296
2013
Q3
Sell
-3
Closed -$4K 5329
2013
Q2
$4K Buy
+3
New +$5.79K ﹤0.01% 5314

Other funds holding CVM

Morgan Stanley's CVM Position: Q2 2026 in Review

Morgan Stanley increased its CEL-SCI Corp (CVM) stake by 5.1% in Q2 2026, buying an estimated $4 and bringing the position to 41 shares worth $43. The position accounts for ﹤0.01% of the portfolio, ranked #8135.

Morgan Stanley first reported a position in CVM in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.27M in Q3 2019. 41 funds tracked by Wall St. Rank hold CVM as of Q2 2026.

  • Morgan Stanley held 41 shares of CEL-SCI Corp worth $43 as of Q2 2026.
  • Morgan Stanley bought 2 CEL-SCI Corp shares in Q2 2026, an estimated $4.
  • CEL-SCI Corp made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #8135 holding.
  • Morgan Stanley first reported a position in CEL-SCI Corp in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's CEL-SCI Corp position peaked at $2.27M in Q3 2019.
  • 41 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.